Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines. - Wikidata - wikimedia - TriplyDB

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

http://www.wikidata.org/entity/Q37634138

about

Alzheimer's disease: is a vaccine possible?Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

P2860

Q33861011-6A08FB36-D74D-48D7-BDF2-CDFF6208E49E Q45300233-C3BAFFE7-1D12-4816-9A0C-5FF2603BD35F

P2860

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

http://www.wikidata.org/entity/Q37634138

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@en

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@nl

type

label

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@en

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@nl

prefLabel

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@en

Immunostimulant patches contai ...... Alzheimer's disease vaccines.

@nl

P1433

Q37634138-EC8332E4-54E3-4202-811F-67CE02E52E0A

P1476

Q37634138-D2C7B59A-A234-40E3-BE60-B6BE9ADF2629

P2093

Q37634138-120ABA04-89D5-4B2D-8698-D679FF68CCCF

Q37634138-3E5578BC-072B-40C6-9544-7D85C1BCFFAE

Q37634138-574275E5-382A-4671-9B8D-C7BDDC003EC7

Q37634138-7CC672F4-D963-4BBE-B53E-9D09D0E8E935

Q37634138-A92D20E6-77E1-4A88-B9E6-1B003C2CEBB1

Q37634138-C7873A6F-A537-42F5-808D-67E41CF8B502

Q37634138-CEB9802E-B87A-462A-97C8-D2BB5F4475D2

Q37634138-F5251054-61AF-4405-9DAB-8501B4957DDE

Q37634138-F8F95447-8519-496E-AB8C-33252C2F3A7A

P2860

Q37634138-01E68670-5889-4A14-ADDC-A94BEBF83452

Q37634138-104ADF00-8AA8-4E63-A1A4-855A869D5C63

Q37634138-10BFADE3-0EDC-4E29-9671-E422E65A251F

Q37634138-1F39E9BB-063B-4EDB-8189-7A9228E5EB7B

Q37634138-2205711D-842E-462B-82B3-5E34FD62D8B9

Q37634138-24E4990C-7018-4294-8361-6A95591B07CB

Q37634138-2E0347F7-2911-4ECD-B811-DB0B8A6BE493

Q37634138-310131DE-793D-4882-BB9F-C044101C9F7E

Q37634138-38A32DCF-1410-41C8-8924-E3781E5FF9C4

Q37634138-38CB9A5E-F190-4900-85EA-7782FE5DE980

P304

Q37634138-141C1073-2FC3-4D3E-9F7A-612765397449

P31

Q37634138-9E8CCAD5-BAB4-4D3A-8ADC-6848AC42D95B

P356

Q37634138-86CDE5F8-C445-4F15-AAFF-DD2C4657C40F

P433

Q37634138-2556E4A0-609D-4B70-A36F-62C8D0A87D80

P478

Q37634138-E189BE9C-2B90-4987-8FD4-1FBE30527AC0

P50

Q37634138-B058C823-11C9-4B1B-93D0-200F3FC3B633

P577

Q37634138-FAFBA631-EE40-4D10-8936-2C56466F259A

P698

Q37634138-E116C991-A2C0-4649-B754-FF85B104E233

P921

Q37634138-F58744E4-14D6-461A-B473-060188318615

P932

Q37634138-E29DA948-7F95-4985-B474-C5B9467B252B

P356

J.JNEUROIM.2014.01.002

P1433

Journal of Neuroimmunology

P1476

Immunostimulant patches contai ...... d Alzheimer's disease vaccines

@en

P2093

Armine Hovakimyan

http://www.w3.org/2001/XMLSchema#string

David Flyer

http://www.w3.org/2001/XMLSchema#string

David H Cribbs

http://www.w3.org/2001/XMLSchema#string

Hayk Davtyan

http://www.w3.org/2001/XMLSchema#string

Irina Petrushina

http://www.w3.org/2001/XMLSchema#string

Jianmei Yu

http://www.w3.org/2001/XMLSchema#string

Lars Ostergaard Pedersen

http://www.w3.org/2001/XMLSchema#string

Michael G Agadjanyan

http://www.w3.org/2001/XMLSchema#string

Peter Juul Madsen

http://www.w3.org/2001/XMLSchema#string

P2860

Forecasting the global burden of Alzheimer’s disease

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Alzheimer's disease: the amyloid cascade hypothesis

Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch.

Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.

DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology

Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations.

P304

50-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2014.01.002

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

268

http://www.w3.org/2001/XMLSchema#string

P50

Anahit Ghochikyan

P577

2014-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24507620

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3951952

http://www.w3.org/2001/XMLSchema#string